3rd Quarter - Report

INDIVIOR INC for INDIVIOR INC

Period 3rd Quarter 2025 Filed Oct 20, 2025 Signed by Kinn Elliott

Official filing
Firm
INDIVIOR INC
Client
INDIVIOR INC
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SUPPORT for Patients and Communities Reauthorization Act (HR 2483); HALT Fentanyl Act (HR 27 / S 331); Reentry Act (HR 2586); Due Process Continuity of Care Act (HR 1510); One Big Beautiful Bill Act (HR 1); FY26 appropriations for Labor-HHS-Education, Military Construction and Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40).

LobbyistCovered position, as disclosed
FRANK J. PURCELL —

Contacted: HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2483 (119th), H.R. 27 (119th), H.R. 1 (119th), H.R. 1510 (119th), H.R. 2586 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.